1. Home
  2. WIMI vs CTXR Comparison

WIMI vs CTXR Comparison

Compare WIMI & CTXR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • WIMI
  • CTXR
  • Stock Information
  • Founded
  • WIMI 2015
  • CTXR 2007
  • Country
  • WIMI China
  • CTXR United States
  • Employees
  • WIMI 107
  • CTXR N/A
  • Industry
  • WIMI Computer Software: Prepackaged Software
  • CTXR Biotechnology: Pharmaceutical Preparations
  • Sector
  • WIMI Technology
  • CTXR Health Care
  • Exchange
  • WIMI Nasdaq
  • CTXR Nasdaq
  • Market Cap
  • WIMI 23.9M
  • CTXR 23.5M
  • IPO Year
  • WIMI 2020
  • CTXR N/A
  • Fundamental
  • Price
  • WIMI $3.18
  • CTXR $1.67
  • Analyst Decision
  • WIMI
  • CTXR Strong Buy
  • Analyst Count
  • WIMI 0
  • CTXR 3
  • Target Price
  • WIMI N/A
  • CTXR $53.00
  • AVG Volume (30 Days)
  • WIMI 7.6M
  • CTXR 2.0M
  • Earning Date
  • WIMI 01-01-0001
  • CTXR 08-11-2025
  • Dividend Yield
  • WIMI N/A
  • CTXR N/A
  • EPS Growth
  • WIMI N/A
  • CTXR N/A
  • EPS
  • WIMI N/A
  • CTXR N/A
  • Revenue
  • WIMI $84,137,968.00
  • CTXR N/A
  • Revenue This Year
  • WIMI N/A
  • CTXR N/A
  • Revenue Next Year
  • WIMI N/A
  • CTXR N/A
  • P/E Ratio
  • WIMI N/A
  • CTXR N/A
  • Revenue Growth
  • WIMI 19.25
  • CTXR N/A
  • 52 Week Low
  • WIMI $0.27
  • CTXR $0.65
  • 52 Week High
  • WIMI $2.92
  • CTXR $26.25
  • Technical
  • Relative Strength Index (RSI)
  • WIMI 60.88
  • CTXR 57.16
  • Support Level
  • WIMI $2.73
  • CTXR $1.49
  • Resistance Level
  • WIMI $3.09
  • CTXR $2.48
  • Average True Range (ATR)
  • WIMI 0.26
  • CTXR 0.29
  • MACD
  • WIMI 0.15
  • CTXR -0.01
  • Stochastic Oscillator
  • WIMI 83.58
  • CTXR 45.64

About WIMI WiMi Hologram Cloud Inc.

WiMi Hologram Cloud Inc and its subsidiaries offer augmented reality (AR) based holographic services and products to cater to its customers. Its AR service and product offerings consist of holographic AR advertising services and holographic AR entertainment products. It is also into the semiconductor business, in which the company provides central processing algorithm services and computer chip products to enterprise customers and the sales of comprehensive solutions for central processing algorithms and related services with software and hardware integration. The company reports in three segments: AR advertising, AR entertainment, and Semiconductor. Its geographical segments are Mainland China, Hong Kong, and International.

About CTXR Citius Pharmaceuticals Inc.

Citius Pharmaceuticals Inc is a biopharmaceutical company with a focus on anti-infectives in adjunct cancer care, prescription products, and stem cell therapy. The company is currently advancing four proprietary product candidates namely, LYMPHIR for the treatment of patients with persistent or recurrent cutaneous T-cell lymphoma. Mino-Lok, which is an antibiotic lock solution used to treat patients with catheter-related bloodstream infections, Mino-Wrap, a liquifying gel-based wrap for reduction of tissue expander infections following breast reconstructive surgeries, Halo-Lido, a topical formulation that is intended to provide anti-inflammatory and anesthetic relief to persons suffering from hemorrhoids, and others.

Share on Social Networks: